Inventor · disambiguated record
Erwin Irdam
Also filed as: IRDAM ERWIN · IRDAM ERWIN AYANDRA
7 granted patents·7 pending applications·48 citations·filing 2012–2024
83Inventor score
Top patents by PatentIndex Score
14 records- 0195US11453641B2Methods of treating neurofibromatosis with N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamideWARNER LAMBERT CO·Filed 2021·Granted Sep 27, 2022·21 cites·6 claims
- 0295US11066358B1Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereofWARNER LAMBERT CO·Filed 2021·Granted Jul 20, 2021·19 cites·10 claims
- 0383US10208003B2Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compoundsKNOPP BIOSCIENCES LLC·Filed 2016·Granted Feb 19, 2019·3 cites·65 claims
- 0482US9512096B2Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compoundsKNOPP BIOSCIENCES LLC·Filed 2012·Granted Dec 6, 2016·3 cites·53 claims
- 0582US2025002449A1Compositions of essentially pure form iv of n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereofWARNER LAMBERT CO·Filed 2024·Application pending·0 cites
- 0680US11291642B2Dimethyl fumarate particles and pharmaceutical compositions thereofBIOGEN MA INC·Filed 2016·Granted Apr 5, 2022·2 cites·14 claims
- 0779US12037306B2Methods of treating neurofibromatosis type 1 with N-((R))-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamideWARNER LAMBERT CO·Filed 2022·Granted Jul 16, 2024·0 cites·16 claims
- 0862US2022362195A1Dimethyl fumarate particles and pharmaceutical compositions thereofBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 0959US2024400506A1Diroximel fumarate particles having improved flow properties and methods of making sameBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 1058US2022356154A1Process for preparing alpha-carboxamide pyrrolidine derivativesBIOGEN INC·Filed 2021·Application pending·0 cites
- 1158US2024308958A1Synthetic preparation for diroximel fumarateBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 1257US2022098150A1Novel Crystalline FormsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 1355US11192856B2Process for preparing alpha-carboxamide pyrrolidine derivativesBIOGEN INC·Filed 2018·Granted Dec 7, 2021·0 cites·19 claims
- 1448US2020062705A1Novel crystalline formsBIOGEN MA INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Erwin Irdam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →